☰

CBER Plans for Monitoring COVID-19 Vaccine Safety and Effectivenes

https://www.fda.gov/media/143557/download 

October 22, 2020
US Department of Agriculture
Vaccines and Related Biological Products Advisory Committee Meeting Presentation

This slide appears to be evidence the FDA was aware of the possibility COVID-19 vaccines might incur the listed adverse events in October of 2020.

FDA working list of possible adverse event outcomes

Works of the United States government are not entitled to domestic copyright protection under U.S. law and are therefore in the public domain.

document
clinical trials,COVID-19,FDA approvals,manufacturers,vaccines